T 2562/18 of 21.07.2020
- European Case Law Identifier
- ECLI:EP:BA:2020:T256218.20200721
- Date of decision
- 21 July 2020
- Case number
- T 2562/18
- Petition for review of
- -
- Application number
- 11153847.6
- IPC class
- A61M 1/36
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Citrate anticoagulation system for extracorporeal blood treatments
- Applicant name
- Nikkiso Co., Ltd.
- Opponent name
- B. Braun Avitum AG
Fresenius Medical Care AG & Co. KGaA - Board
- 3.2.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(b) (2007)European Patent Convention Art 123(2) (2007)European Patent Convention Art 54(1) (2007)European Patent Convention Art 54(2) (2007)European Patent Convention Art 56 (2007)European Patent Convention Art 76(1) (2007)European Patent Convention Art 84 (2007)
- Keywords
- Grounds for opposition - insufficiency of disclosure (no)
Novelty - main request (no)
Novelty - auxiliary request 2 (yes)
Claims - clarity
Claims - auxiliary requests 1 and 2 (yes)
Amendments - extension beyond the content of the original
application and the parent application as filed - auxiliary
request 1 (yes) - auxiliary request 2 (no)
Inventive step - auxiliary request 2 (yes) - Catchword
- -
- Cited cases
- T 0404/16
- Citing cases
- T 0404/16
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the Opposition Division with the order to maintain the patent as amended in the following version:
- claims: 1-9 according to auxiliary request 2 filed with letter dated 16 May 2019;
- description: pages 2, 4-7, 9 of the patent specification, and pages 3 and 8 filed during the oral proceedings before the Opposition Division on 2 July 2018;
- drawings: Figures 1-6 of the patent specification.